Skip to content
AnalystLens
Back to HALOIncome Statement

Halozyme Therapeutics Gross Profit 2009-2026 | HALO

Annual FY2009–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$1.17B

+36.4%YoY vs FY2024Source: 10-KFY2025

From $13.4M in FY2009 to $1.17B in FY2025: 87.4× in 16 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$297M+37.4%$402M+43.8%$410M+37.3%Not reported
FY25$216M+29.2%$279M+45.7%$299M+24.3%$373M+45.7%
FY24$168M+32.0%$192M+12.2%$241M+49.3%$256M+44.0%
FY23$127M+25.3%$171M+44.4%$161M−0.3%$178M+27.5%
FY22$101M+43.2%$118M+4.4%$162M+66.2%$139M+73.3%
Share19%22%28%31%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+39.1%

FY2020
$224.2M
FY2025
$1.17B

5 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $1.17B
YoY changeLargest recent move+151.5%in FY17Latest +36.4%

2 older moves run past ±150% (largest +341.7%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2025$1.17B+36.4%10-K
FY2024$855.9M+34.4%10-K
FY2023$636.9M+22.3%10-K
FY2022$520.8M+43.9%10-K
FY2021$361.9M+61.4%10-K
FY2020$224.2M+49.0%10-K
FY2019$150.4M+6.2%10-K
FY2018$141.7M−50.4%10-K
FY2017$285.5M+151.5%10-K
FY2016$113.5M+7.3%10-K
FY2015$105.8M+101.2%10-K
FY2014$52.6M+8.3%10-K
FY2013$48.6M+17.8%10-K
FY2012$41.2M−26.1%10-K
FY2011$55.8M+341.7%10-K
FY2010$12.6M−5.4%10-K
FY2009$13.4M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Halozyme Therapeutics's current gross profit?

Halozyme Therapeutics (HALO) annual gross profit for 2025 was $1.17B, a 36.44% increase from 2024. Halozyme Therapeutics gross profit for the quarter ending September 30, 2026 was $410.5M.

What was Halozyme Therapeutics's gross profit in 2024?

Halozyme Therapeutics annual gross profit for 2024 was $855.9M, a 34.39% increase from 2023.

What was Halozyme Therapeutics's gross profit in 2023?

Halozyme Therapeutics annual gross profit for 2023 was $636.9M, a 22.29% increase from 2022.

What is Halozyme Therapeutics's 5-year gross profit CAGR?

Halozyme Therapeutics gross profit grew at a compound annual growth rate (CAGR) of 39.10% from FY2020 to FY2025, going from $224.2M to $1.17B over 5 years.

Company
Halozyme Therapeutics
Ticker
HALO
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)